212 related articles for article (PubMed ID: 24217821)
1. First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.
Cho YT; Lee FY; Chu CY; Wang LF
Acta Derm Venereol; 2014 Jul; 94(4):472-3. PubMed ID: 24217821
[No Abstract] [Full Text] [Related]
2. Management of pemphigus in pediatric patients.
Gürcan H; Mabrouk D; Razzaque Ahmed A
Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
4. Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.
Craythorne EE; Mufti G; DuVivier AW
J Am Acad Dermatol; 2011 Nov; 65(5):1064-5. PubMed ID: 22000877
[No Abstract] [Full Text] [Related]
5. [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].
Hammers CM; Schmidt E; Zillikens D
Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1473-7. PubMed ID: 24983196
[No Abstract] [Full Text] [Related]
6. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
Reguiai Z; Tabary T; Maizières M; Bernard P
J Am Acad Dermatol; 2012 Oct; 67(4):623-9. PubMed ID: 22261417
[TBL] [Abstract][Full Text] [Related]
8. Current therapy of the pemphigus group.
Kasperkiewicz M; Schmidt E; Zillikens D
Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
[TBL] [Abstract][Full Text] [Related]
9. The actual management of pemphigus.
Daniel BS; Murrell DF
G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
[TBL] [Abstract][Full Text] [Related]
10. Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone.
Chiu HY; Chang CY; Hsiao CH; Wang LF
Acta Derm Venereol; 2013 Mar; 93(2):200-1. PubMed ID: 22948546
[No Abstract] [Full Text] [Related]
11. Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
Baum S; Gilboa S; Greenberger S; Pavlotsky F; Trau H; Barzilai A
J Dermatolog Treat; 2013 Dec; 24(6):427-30. PubMed ID: 23521340
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
Craythorne E; du Viver A; Mufti GJ; Warnakulasuriya S
J Oral Pathol Med; 2011 Sep; 40(8):616-20. PubMed ID: 21385212
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.
Ingen-Housz-Oro S; Alexandre M; Le Roux-Villet C; Picard-Dahan C; Tancrède-Bohin E; Wallet-Faber N; Mahé E; Begon E; Francès C; Sigal M; Grootenboer-Mignot S; Aucouturier F; André C; Wolkenstein P; Chosidow O; Prost-Squarcioni C
J Am Geriatr Soc; 2012 Jun; 60(6):1185-7. PubMed ID: 22690997
[No Abstract] [Full Text] [Related]
14. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients.
Leshem YA; Hodak E; David M; Anhalt GJ; Mimouni D
J Am Acad Dermatol; 2013 Mar; 68(3):404-11. PubMed ID: 23044076
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rituximab treatment in Indian pemphigus patients.
Kanwar AJ; Tsuruta D; Vinay K; Koga H; Ishii N; Dainichi T; Hashimoto T
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e17-23. PubMed ID: 22176540
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus.
Shaik F; Botha J; Aboobaker J; Mosam A
Clin Exp Dermatol; 2010 Apr; 35(3):245-50. PubMed ID: 19874327
[TBL] [Abstract][Full Text] [Related]
17. Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.
Mabrouk D; Ahmed AR
Pediatr Dermatol; 2011; 28(5):485-93. PubMed ID: 21883426
[TBL] [Abstract][Full Text] [Related]
18. [Immunodepressants in the overall therapy of pemphigus].
Kalamkarian AA; Trofimova LIa; Khapilova VI
Vestn Dermatol Venerol; 1979 Dec; (12):28-32. PubMed ID: 525019
[No Abstract] [Full Text] [Related]
19. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
[No Abstract] [Full Text] [Related]
20. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Matsukura S; Knowles SR; Walsh S; Shear NH
Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
